EMG
URGN icon

ETF Managers Group’s UroGen Pharma URGN Stock Holding History

ETF Managers Group’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,560
Closed -$367K – 755
2021
Q3 		$367K Sell
21,560
-1,484
-6% -$23.5K 0.01% 578
2021
Q2 		$367K Sell
23,044
-16,648
-42% -$301K 0.01% 572
2021
Q1 		$735K Buy
39,692
+7,089
+22% +$151K 0.01% 323
2020
Q4 		$590K Buy
32,603
+3,919
+14% +$82.1K 0.01% 306
2020
Q3 		$554K Buy
28,684
+2,230
+8% +$50.5K 0.02% 289
2020
Q2 		$673K Buy
26,454
+2,864
+12% +$70K 0.02% 233
2020
Q1 		$428K Buy
23,590
+2,096
+10% +$56.6K 0.02% 230
2019
Q4 		$731K Buy
21,494
+1,638
+8% +$44.7K 0.03% 222
2019
Q3 		$476K Buy
19,856
+2,161
+12% +$70.6K 0.02% 265
2019
Q2 		$583K Buy
17,695
+5,985
+51% +$221K 0.02% 239
2019
Q1 		$433K Sell
11,710
-377
-3% -$15.8K 0.02% 243
2018
Q4 		$520K Buy
12,087
+1,541
+15% +$69.3K 0.02% 225
2018
Q3 		$498K Buy
+10,546
New +$490K 0.02% 222
2018
Q2 		– Sell
-8,161
Closed -$395K – 592
2018
Q1 		$395K Buy
8,161
+1,316
+19% +$65.9K 0.02% 218
2017
Q4 		$264K Buy
+6,845
New +$244K 0.02% 208

Other funds holding URGN

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

ETF Managers Group's URGN Position: Q4 2021 in Review

ETF Managers Group sold out of UroGen Pharma (URGN) in Q4 2021, closing a stake of 21,560 shares — an estimated $367K sold.

ETF Managers Group first reported a position in URGN in Q4 2017 and held it in 15 quarters. The position peaked at $735K in Q1 2021. 78 funds tracked by Wall St. Rank hold URGN as of Q4 2021.

  • ETF Managers Group reported no remaining UroGen Pharma position as of Q4 2021 after selling out during the quarter.
  • ETF Managers Group sold 21,560 UroGen Pharma shares in Q4 2021, an estimated $367K.
  • ETF Managers Group first reported a position in UroGen Pharma in Q4 2017 and held it in 15 quarters.
  • ETF Managers Group's UroGen Pharma position peaked at $735K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held UroGen Pharma as of Q4 2021.

Based on ETF Managers Group's 13F filing for Q4 2021, filed 14 Feb 2022.